Wednesday, December 2 2026
11:30am–12:30pm
CME/CE
Gut Club: Advances in Irritable Bowel Syndrome and Colorectal Cancer Screening
Description
Stay current on two high-impact GI topics relevant to every primary care practice. This activity covers the latest evidence-based treatments for IBS and chronic idiopathic constipation alongside a practical look at colorectal cancer screening with an emphasis on non-invasive tests— giving you actionable guidance you can apply with your patients right away.
Learning Objectives
- Discuss efficacy, safety, and evidence-based guidelines of IBS and CIC treatment with OTC and prescription therapies
- Discuss strengths and limitations of non-invasive tests for CRC screening
Faculty
Education Partner
- EBMed
Supported by
- Ironwood Pharmaceuticals, Inc. (in partnership with AbbVie Inc), Ardelyx, Inc., and Exact Sciences Corporation